Canadians with cancer and those at risk will have the best available cancer treatments through access to and efficient execution of academic cancer clinical trials.
To support and improve the efficient delivery of cancer clinical trial results that will define medical practice by addressing impediments to patient access and execution of academic cancer clinical trials through funding, resources, and advocacy to improve the clinical trial environment.
Goals and objectives
- To improve patient access to academic clinical trials;
- To improve patient and public involvement (PPI) across all sites and provide assistance for development and implementation of PPI;
- To improve the trial environment for the conduct of academic clinical trials through collaboration and facilitation of important national trial initiatives;
- To optimize the 3CTN trial Portfolio to create opportunities for new trials and to demonstrate its impact.